Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin.
Zucali PA, Giovannetti E, Destro A, Mencoboni M, Ceresoli GL, Gianoncelli L, Lorenzi E, De Vincenzo F, Simonelli M, Perrino M, Bruzzone A, Thunnissen E, Tunesi G, Giordano L, Roncalli M, Peters GJ, Santoro A. Zucali PA, et al. Among authors: mencoboni m. Clin Cancer Res. 2011 Apr 15;17(8):2581-90. doi: 10.1158/1078-0432.CCR-10-2873. Epub 2011 Jan 24. Clin Cancer Res. 2011. PMID: 21262916 Clinical Trial.
Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma.
Landi S, Gemignani F, Neri M, Barale R, Bonassi S, Bottari F, Canessa PA, Canzian F, Ceppi M, Filiberti R, Ivaldi GP, Mencoboni M, Scaruffi P, Tonini GP, Mutti L, Puntoni R. Landi S, et al. Among authors: mencoboni m. Int J Cancer. 2007 Jun 15;120(12):2739-43. doi: 10.1002/ijc.22590. Int J Cancer. 2007. PMID: 17290392 Free article.
Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer.
Cristaudo A, Foddis R, Vivaldi A, Guglielmi G, Dipalma N, Filiberti R, Neri M, Ceppi M, Paganuzzi M, Ivaldi GP, Mencoboni M, Canessa PA, Ambrosino N, Chella A, Mutti L, Puntoni R. Cristaudo A, et al. Among authors: mencoboni m. Clin Cancer Res. 2007 Sep 1;13(17):5076-81. doi: 10.1158/1078-0432.CCR-07-0629. Clin Cancer Res. 2007. PMID: 17785560
Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM).
Castagneto B, Botta M, Aitini E, Spigno F, Degiovanni D, Alabiso O, Serra M, Muzio A, Carbone R, Buosi R, Galbusera V, Piccolini E, Giaretto L, Rebella L, Mencoboni M. Castagneto B, et al. Among authors: mencoboni m. Ann Oncol. 2008 Feb;19(2):370-3. doi: 10.1093/annonc/mdm501. Epub 2007 Dec 20. Ann Oncol. 2008. PMID: 18156144 Free article. Clinical Trial.
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.
Ceresoli GL, Castagneto B, Zucali PA, Favaretto A, Mencoboni M, Grossi F, Cortinovis D, Del Conte G, Ceribelli A, Bearz A, Salamina S, De Vincenzo F, Cappuzzo F, Marangolo M, Torri V, Santoro A. Ceresoli GL, et al. Among authors: mencoboni m. Br J Cancer. 2008 Jul 8;99(1):51-6. doi: 10.1038/sj.bjc.6604442. Epub 2008 Jun 10. Br J Cancer. 2008. PMID: 18542071 Free PMC article.
Solitary fibrous tumor.
Bruzzone A, Varaldo M, Ferrarazzo C, Tunesi G, Mencoboni M. Bruzzone A, et al. Among authors: mencoboni m. Rare Tumors. 2010 Dec 31;2(4):e64. doi: 10.4081/rt.2010.e64. Rare Tumors. 2010. PMID: 21234256 Free PMC article.
Individual predictors of increased serum mesothelin in asbestos-exposed workers.
Filiberti R, Marroni P, Mencoboni M, Mortara V, Caruso P, Cioè A, Michelazzi L, Merlo DF, Bruzzone A, Bobbio B, Del Corso L, Galli R, Taveggia P, Dini G, Spigno F. Filiberti R, et al. Among authors: mencoboni m. Med Oncol. 2013 Mar;30(1):422. doi: 10.1007/s12032-012-0422-6. Epub 2013 Jan 1. Med Oncol. 2013. PMID: 23277285
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma.
Ceresoli GL, Zucali PA, Mencoboni M, Botta M, Grossi F, Cortinovis D, Zilembo N, Ripa C, Tiseo M, Favaretto AG, Soto-Parra H, De Vincenzo F, Bruzzone A, Lorenzi E, Gianoncelli L, Ercoli B, Giordano L, Santoro A. Ceresoli GL, et al. Among authors: mencoboni m. Br J Cancer. 2013 Aug 6;109(3):552-8. doi: 10.1038/bjc.2013.368. Epub 2013 Jul 16. Br J Cancer. 2013. PMID: 23860535 Free PMC article. Clinical Trial.
Is soluble mesothelin-related protein an upfront predictive marker of pleural mesothelioma? A prospective study on Italian workers exposed to asbestos.
Filiberti R, Marroni P, Spigno F, Merlo DF, Mortara V, Caruso P, Cioè A, Michelazzi L, Bruzzone A, Bobbio B, Simonassi C, Del Corso L, Galli R, Racchi O, Dini G, Linares R, Mencoboni M. Filiberti R, et al. Among authors: mencoboni m. Oncology. 2014;86(1):33-43. doi: 10.1159/000355687. Epub 2013 Dec 21. Oncology. 2014. PMID: 24401539
94 results